Trial intelligence / Profile preview

EVP-6124 for Smoking Cessation

NCT01480232Phase 2Terminated

Start
Dec 2011
Primary completion
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of encenicline in nicotine dependence. Started Dec 2011; status: terminated.

02

Drugs

encenicline
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NCT01480232.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01480232.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call